Objectives: To identify temporal patterns of patient-reported trismus during the first year post-radiotherapy, and to study their associations with maximal interincisal opening distances (MIOs).
oncological treatment (post-RT) 3, 4 . Mouth-opening ability is not always routinely assessed in post-RT follow-up 5 , and several studyspecific definitions and cut-off values for trismus have been developed 4 . Currently, the gold standard trismus definition is represented by a maximal interincisal opening distance (MIO) ≤35 mm 4, 6, 7 . However, knowledge on how such trismus measures relate to the impairment from the patient's perspective is limited but is needed to better understand the clinical significance of mouth-opening measurements 1, 2 .
Trismus leads to eating and speech difficulties, impaired oral hygiene, altered facial expression, pain, reduced nutrition and has considerable negative impact on quality of life 5, 8, 9 . Also, the presence of trismus in HNC patients may interfere with proper physical and dental examinations, thereby limiting possibilities to identify a relapse.
Prevention of trismus is important as once trismus occurs, it is difficult to treat and often becomes permanent [3] [4] [5] . Johnson et al. 10 introduced a trismus-specific patient-reported outcome instrument, the Gothenburg Trismus Questionnaire (GTQ), which successfully has been used to quantify trismus in HNC following RT [10] [11] [12] . Provided temporal information on the GTQ domains and MIO, relationships between temporally robust GTQ items and MIO could be identified to widen possibilities to monitor and prevent trismus post-RT in HNC.
The aim of this work was to investigate temporal patterns of radiation-induced trismus at various time points within the first year after RT for HNC with the ultimate goal to increase the general understanding and monitoring of this injury. More specifically, the association between temporally robust trismus domains of GTQ and mouth-opening ability, as assessed by MIO, was studied.
| MATERIALS AND METHODS

| Ethical considerations
Patient data were collected from electronic case records and questionnaires and reviewed only by members of the responsible research team. The local ethics board approved the study and written informed consent was received from all participants.
| Study design and participants
This prospective cohort study was conducted between 2007 and 2012 at the Sahlgrenska University Hospital, Gothenburg, Sweden.
Details on the cohort have previously been described 11 . In brief, the study population inclusion criteria were consecutively recruited HNC patients treated with RT with/without chemotherapy but not with surgery for tumours of the nasopharynx, oral cavity (floor of mouth, gum, soft palate or tongue), oropharynx (base of tongue or tonsil), lip, nasal cavity, salivary gland, sinuses or tumour colli. Patients had to be able to read and understand the questionnaires and were not to have undergone palliative treatment, being edentulous or in poor general health. For the purpose of this work, patients were in addition not included if participating in an associated intervention study using a structured exercise programme nor if having MIO≤35 mm at baseline. In total, 215 subjects who had been treated to 64.6/68 Gy in 38/34 fractions, respectively, fulfilled the inclusion criteria.
| Trismus assessments
Three sources of information regarding trismus, all assessed at baseline and at 3/6/12 months post-RT, were considered for this study.
Two patient-reported outcome instruments were used as follows:
the GTQ
10
, and the HNC-specific module of the European Organization for Research and Treatment of Cancer quality of life Questionnaire (EORTC QLQ-H&N35) 13 . The GTQ includes 21 items on eating limitations, jaw-related problems, muscular tension, pain and impact on quality of life (QoL), generally with a one-week-recall period and with a 1-5 answering classification (1: not at all; 5: very severe) 10 .
The HNC-specific module of EORTC QLQ-H&N35 13 includes 35 items classified from 1 to 4, of which the two items "Did you experience pain in your jaw" and "Did you have difficulties opening your mouth" were included here. The Likert scale answering categories of both patient-reported outcome instruments are translated into equally distributed scores between 0 and 100 (0/100 indicates the lowest/highest symptom severity). An overview of all considered GTQ and EORTC QLQ-HN35 items, and their answering categories are given in Table S1 . MIO was measured with a ruler as the distance between the edges of the incisors of the mandible and the maxilla (mm accuracy), and with the subject in an upright position 11 .
| Statistical analysis
Temporally robust symptom domains were identified from our factor analysis methodology, which was previously applied to group radiation-induced patient-reported items for prostate cancer 14 . A detailed description of this approach can be found in the Appendix S1 [14] [15] [16] [17] [18] [19] .
Exploratory followed by confirmatory factor analysis was carried out in R using the Psych 20 and Lavaan 21 packages with the comparative fit index used as a measure of factor model agreement.
Items in an identified temporally robust domain were correlated with MIO using Pearson's correlation coefficients (P r ). For the GTQ items with seven answering categories, categories 2 and 3 were combined into one category corresponding to a "mild" symptom severity; answering categories 6 and 7 were combined into a "very severe" answering category. As GTQ items are measured on a categorical scale and MIO on a continuous scale, five GTQ-corresponding MIO categories were defined: 1: >50 mm; 2:
Keypoints
• Using patient-reported outcomes, four temporally robust trismus symptoms domains were identified the first year after HNC RT with 2-3 persisting symptoms each.
• is recommended as the clinical cut-off level for trismus 4, 6 . Similarly, the EORTC QLQ-H&N35 items were correlated with a recategorised MIO, but for these analyses MIO categories 4 and 5
were combined into one because the answering categories of the EORTC QLQ-H&N35 ranged from 1 to 4. Relative risks (RRs) and related 95% confidence intervals were calculated relative to baseline for all GTQ items, the two EORTC QLQ-H&N35 items, as well as for MIO. All symptoms and MIO were analysed for at least moderate cut-off (answering category >2), and at least severe cut-off (answering category >3).
3 | RESULTS
| Patient characteristics
In total, 196 subjects presented with complete patient-reported outcome data and MIO information at baseline and were retained for analysis ( Table 1 ). The majority of these subjects were men (72%), treated with chemo-RT (70%), and their mean AE SD age was 60AE11 years. Almost two-thirds were former or current smokers (62%). Primary tumours were predominantly located in the oropharynx (66%), and more specifically in the tonsil (47%) or the base of tongue (13%). T-stage was typically ≥T2 (73%); N-stage was predominantly N2 or N3 (57%). These characteristics remained stable in rate over time, although the number of subjects with complete data decreased to 186/152/149 at 3/6/12 months post-RT, respectively.
| Trismus assessments
For the GTQ scores, the population mean AE SD of all 21 items increased from 10AE6 to 18-26AE9-11 post-RT (Table S2) 
| Relative change in symptom occurrence over time with respect to baseline
The occurrence of at least moderate symptom cut-off (answering category >2) increased for all GTQ items at some follow-up time (23) 42 (23) 34 (22) 33 (22) Missing 8 (4) 8 (4) 7 (5) 5 (3) Tumour site, n (%) Nasopharynx 12 (6) 12 (6) 8 (5) 8 (5) Oral cavity, tot.
24 (12) 24 (13) 23 (15) 20 (13) Floor of mouth 6 (3) 7 (4) 6 (4) 4 (3) Soft palate 4 (2) 3 (2) 3 (2) 4 (3) Tongue 13 (7) 13 (7) 13 (9) 11 (7) Unspecified 
| GTQ-symptom domains
The best-fitting models were obtained for five-factor solutions at baseline (comparative fit index: 0.93; Table S4 ), and at 3 and at 12 months post-RT (comparative fit index: 0.96 and 0.88, respectively), and for a four-factor solution at 6-month post-RT (comparative fit index: 0.97). The four symptom domains identified at each followup included items related to jaw function (Jaw), eating ability (Eating), pain (Pain) and QoL ( Tables 2 and S5 ). These temporally robust symptom domains were at most modestly correlated with each other (P r ≤.65), with the stronger correlations occurring most frequently between Jaw and QoL (P r =.56-.64). For Jaw, GTQ2 and 3 were identified at each follow-up. Similarly, GTQ8-10 remained as temporally robust symptoms for Eating, GTQ15 and 16 for Pain and GTQ20 and 21 for QoL. The RRs and corresponding 95% confidence intervals for these nine temporally robust symptoms are illustrated for at least a moderate, and at least a severe symptom cut-off in Figure 1 .
| Relationships between temporally robust GTQ symptoms and MIO post-RT
For the temporally robust symptoms of any GTQ domain, the correlations with MIO over all follow-up times were at most moderate (P r =.19-.55; Table 3 ; Figure 2 ). The Jaw and QoL domains presented Relationships between mouth-opening distances and perceived physical problems due to trismus have been addressed previously 1, 6 . A recent study by Wetzels et al. 1 found that mouthopening inability at 1-year post-RT in patients with oral cancer (RT with/without surgery) was moderately correlated (|P r |=.55) with a self-reported trismus item: "During the past week, have you experienced problems with opening your mouth wide?". In the context of our study, their item would correspond to GTQ item 19 or EORTC QLQ-H&N35 item 40, which presented with correlation coefficients of the same range (|P r |=.53 and .56 at 1-year post-RT, respectively). Although Wetzels et al. 1 measured maximum mouthopening extra-orally, it is interesting to note that the correlation coefficients for our temporally robust QoL items with MIO were also in this range and peaked at 1-year post-RT (|P r |=.45-.55). Furthermore, the RR was higher for the GTQ item 19 (up to fourfold increase) than for the EORTC QLQ-H&N35 item 40 (up to threefold increase), and for both items the RR was typically higher at 3-month post-RT than at 1-year post-RT. Together, these findings suggest that mouth-opening problems within the first year after RT may be easier to detect using five-category scales (mild-very severe) than four-category scales (mild-severe). Our results are also in accordance with previous research, which shows that radiationinduced trismus recovers to some extent during the first year after treatment 1,3,4 .
| Comparison with original GTQ domains from various perspectives
The three GTQ domains originally identified by Johnson et al. 10 in 2012 (eating limitations/jaw-related problems/muscular tension:
4/6/3 items) were not consistent across the time points investigated factor analysis approaches were used; a fixed factor-loading threshold (≥0.40)/scree-plots/total variance to decide the final number of factors/symptom domains in the Johnson study 10 and a comparative fit index-driven exploratory/confirmatory factor analysis approach here. Considering cohort and analysis differences, it is not surprising that the number of identified domains and included number of items or our domains vary from the original GTQ domains. All these aspects will be considered in future work to further develop GTQ.
| Limitations
When interpreting our results, it should be kept in mind that data were taken from one hospital with the treatment approaches in use during the studied period of time. The patients constituted a fairly homogenous group of individuals with respect to age, ethnicity and sex and were recruited within a limited geographical region. Our results concern dentulous HNC patients and may not be fully applicable to edentulous patients or specific cancer diagnoses. Compared to other studies, our reported trismus rates were also in the higher end and peaked typically at 3-month post-RT. This can to some extent be explained by focusing on trismus in a cohort including patients treated with RT alone (surgery causes lower trismus rates 6 ), and also that the 3-month post-RT assessment point might capture remaining early radiation-induced reactions. Finally, our investigated categories of MIO can be criticised to cover too well functioning mouth-opening ability (category indicating the highest dysfunction for MIO<26 mm), which in the objective setting has been denoted moderate impairment 4 . Normal mouth-opening ability, on the other hand, was in our analyses set to MIO>50 mm, which also is a matter of discussion with MIO, GTQ21 12 6 3 F I G U R E 2 Pearson's correlation coefficient (P r ) between each of the 21 Gothenburg Trismus Questionnaire (GTQ) items and MIO at 3/ 6/12 months post-radiotherapy (post-RT). Note: The colour coding on the left hand side follows that of the P r scale on the right hand side associated perceptions of various degrees of symptom severity are, therefore, a compromise between these assumptions, and in addition, our data did not allow for studying a lower MIO cut-off as at most nine patients presented with MIO<26 mm post-RT.
| Clinical applicability of the study
The strengths of our study are a relatively large unselected cohort including subjects consecutively treated for HNC and an objective symptom grouping method applied to prospectively collected data on longitudinally monitored trismus. The correlations between MIO and perceived physical problems due to trismus in our case series are in accordance with other studies, which further improve reliability and applicability of our findings. Specific questions on mouthopening status interfering with social/private life can be used as a screening tool to assess clinically meaningful radiation-induced trismus post-treatment.
| CONCLUSIONS
Our data suggest that a reduction in MIO can be expected as patients communicate their mouth-opening status to interfere with private/social life after RT for HNC. Bearing in mind the importance of timely management of trismus [3] [4] [5] , our results can, therefore, assist in detecting early trismus warning signs. Evidence for structured exercise programmes with jaw mobilising devices to give lasting improvements of trismus-related symptoms is emerging 12, 26 , and offering such interventions as patients indicate mouth-opening problems may help to ameliorate this condition for future patients.
